191 related articles for article (PubMed ID: 16625509)
1. [Anticholinesterases in the treatment of Alzheimer's disease].
Gandía L; Alvarez RM; Hernández-Guijo JM; González-Rubio JM; de Pascual R; Rojo J; Tapia L
Rev Neurol; 2006 Apr 16-30; 42(8):471-7. PubMed ID: 16625509
[TBL] [Abstract][Full Text] [Related]
2. A review on cholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B
Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
[TBL] [Abstract][Full Text] [Related]
3. [Neurotransmitters in Alzheimer's disease].
Manzano-Palomo S; De la Morena-Vicente MA; Barquero MS
Rev Neurol; 2006 Mar 16-31; 42(6):350-3. PubMed ID: 16575771
[TBL] [Abstract][Full Text] [Related]
4. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study.
Mazumder MK; Choudhury S
Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
6. [Acetylcholinesterase inhibitors for treatment of Alzheimer's disease].
Shinagawa S; Shigeta M
Brain Nerve; 2014 May; 66(5):507-16. PubMed ID: 24807367
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of Alzheimer's disease].
López OL; Becker JT
Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington.
Davis KL
Geriatrics; 1999 Feb; 54(2):42-7; quiz 48. PubMed ID: 10024872
[TBL] [Abstract][Full Text] [Related]
9. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
Pákáski M; Kálmán J
Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic function and Alzheimer's disease.
Giacobini E
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S1-5. PubMed ID: 12973744
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.
León R; Garcia AG; Marco-Contelles J
Med Res Rev; 2013 Jan; 33(1):139-89. PubMed ID: 21793014
[TBL] [Abstract][Full Text] [Related]
12. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk GL
J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
[TBL] [Abstract][Full Text] [Related]
13. The neurobiology and pharmacotherapy of Alzheimer's disease.
Felician O; Sandson TA
J Neuropsychiatry Clin Neurosci; 1999; 11(1):19-31. PubMed ID: 9990552
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
da Silva CH; Campo VL; Carvalho I; Taft CA
J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
[TBL] [Abstract][Full Text] [Related]
15. New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease.
Villarroya M; García AG; Marco JL
Curr Pharm Des; 2004; 10(25):3177-84. PubMed ID: 15544507
[TBL] [Abstract][Full Text] [Related]
16. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation.
Brenner T; Nizri E; Irony-Tur-Sinai M; Hamra-Amitay Y; Wirguin I
J Neuroimmunol; 2008 Sep; 201-202():121-7. PubMed ID: 18684515
[TBL] [Abstract][Full Text] [Related]
18. [New therapeutic options in Alzheimer's disease].
García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors.
Tayeb HO; Yang HD; Price BH; Tarazi FI
Pharmacol Ther; 2012 Apr; 134(1):8-25. PubMed ID: 22198801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]